Disc Medicine, Inc. Increase Decrease In Operating Lease Liability
Disc Medicine, Inc. (IRON) reported Increase Decrease In Operating Lease Liability of -$342.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-30
- Disc Medicine, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$174.00K, a 341.67% decline year-over-year.
- Disc Medicine, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$168.00K, a 138.62% decline year-over-year.
- Disc Medicine, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$165.00K.
- Disc Medicine, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$156.00K.
- Disc Medicine, Inc. increase decrease in operating lease liability for fiscal 2025 was $186.00K.
- Disc Medicine, Inc. increase decrease in operating lease liability for fiscal 2024 was -$495.00K.
- Disc Medicine, Inc. increase decrease in operating lease liability for fiscal 2023 was -$54.00K.
- Disc Medicine, Inc. increase decrease in operating lease liability for fiscal 2022 was -$319.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$342.00K 10-Q · filed 2026-07-30 | -$507.00K derived: sum of 3 quarters · filed 2026-07-30 | -$663.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$168.00K 10-Q · filed 2026-05-05 | -$333.00K derived: sum of 2 quarters · filed 2026-05-05 | -$489.00K derived: sum of 3 quarters · filed 2026-05-05 | -$417.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$321.00K derived: sum of 2 quarters · filed 2026-02-26 | -$249.00K derived: sum of 3 quarters · filed 2026-07-30 | $186.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$84.00K derived: sum of 2 quarters · filed 2026-07-30 | $351.00K 10-Q · filed 2025-11-06 | $241.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $507.00K 10-Q · filed 2026-07-30 | $397.00K derived: sum of 3 quarters · filed 2026-07-30 | $276.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $435.00K 10-Q · filed 2026-05-05 | $325.00K derived: sum of 2 quarters · filed 2026-05-05 | $204.00K derived: sum of 3 quarters · filed 2026-05-05 | $15.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$231.00K derived: sum of 2 quarters · filed 2026-02-26 | -$420.00K derived: sum of 3 quarters · filed 2026-02-26 | -$495.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$310.00K derived: sum of 2 quarters · filed 2025-11-06 | -$385.00K 10-Q · filed 2025-11-06 | -$351.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$264.00K 10-Q · filed 2025-08-07 | -$230.00K derived: sum of 3 quarters · filed 2026-02-26 | -$178.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$75.00K 10-Q · filed 2025-05-07 | -$41.00K derived: sum of 2 quarters · filed 2026-02-26 | $11.00K derived: sum of 3 quarters · filed 2026-02-26 | -$53.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $86.00K derived: sum of 2 quarters · filed 2026-02-26 | $22.00K derived: sum of 3 quarters · filed 2026-02-26 | -$54.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$12.00K derived: sum of 2 quarters · filed 2024-11-12 | -$88.00K 10-Q · filed 2024-11-12 | -$161.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$140.00K 10-Q · filed 2024-08-08 | -$213.00K derived: sum of 3 quarters · filed 2024-08-08 | -$399.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$76.00K 10-Q · filed 2024-05-09 | -$149.00K derived: sum of 2 quarters · filed 2024-05-09 | -$335.00K derived: sum of 3 quarters · filed 2024-05-09 | -$318.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$259.00K derived: sum of 2 quarters · filed 2024-03-21 | -$242.00K derived: sum of 3 quarters · filed 2024-03-21 | -$319.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$169.00K derived: sum of 2 quarters · filed 2023-11-09 | -$246.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$60.00K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$77.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$141.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |